13 September 2024
Concurrent Technologies Plc
(the "Company" or the "Group")
Exercise of Share Options, PDMR Dealing, Transaction in Own Shares and Total Voting Rights
Concurrent Technologies PLC (AIM: CNC), a designer and manufacturer of leading-edge computer products, systems and mission critical solutions used in high-performance markets by some of the world's major OEMs, announces that Brent Salgat, Director & Chief Revenue Officer, has exercised share options ("Share Options") over 150,000 ordinary shares of 1 pence each in the Company ("Ordinary Shares") at a price of 39 pence per Ordinary Share. To satisfy the exercise of the Share Options 150,000 Ordinary Shares have been transferred out of treasury.
The Share Options were granted in 2015 under the Enterprise Management Incentive Scheme 2000 and became exercisable following the satisfaction of certain performance criteria. Following the exercise, Mr Salgat as a total interest in 150,000 Ordinary Shares, representing 0.17 per cent of the enlarged share capital.
Total Voting Rights
Following the exercise of the Share Options, the Company has transferred 150,000 Ordinary Shares out of treasury. Accordingly, the Company holds 381,522 Ordinary Shares in treasury and its total number of Ordinary Shares with voting rights is 85,787,714. This figure of 85,787,714 Ordinary Shares may be used by Company's shareholders as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change to their interest in, Concurrent Technologies Plc under the FCA's Disclosure Guidance and Transparency Rules.
Enquiries:
| Concurrent Technologies Plc Kim Garrod - CFO
|
+44 (0)1206 752626
|
| Alma Strategic Communications Hannah Campbell
|
+44 (0)20 3405 0205
|
| Cavendish Capital Markets Limited (NOMAD) Peter Lynch
|
+44 (0)131 220 9772 |
About Concurrent Technologies Plc
Concurrent Technologies Plc develops and manufactures high-end embedded Plug In Cards and Systems for use in a wide range of high performance, long life cycle applications within the telecommunications, defence, security, telemetry, scientific and aerospace markets, including applications within extremely harsh environments. The processor products feature Intel® processors, including the latest generation embedded Intel® Core™ processors, Intel® Xeon® and Intel Atom™ processors. The products are designed to be compliant with industry specifications and support many of today's leading embedded Operating Systems. The products are sold world-wide.
For more information on Concurrent Technologies Plc and its products please visit www.gocct.com.
| 1. | Details of the person discharging managerial responsibilities / person closely associated | ||
| a) | Name | Brent Salgat | |
| 2. | Reason for the Notification | ||
| a) | Position/status | Chief Revenue Officer & Executive Director | |
| b) | Initial notification/amendment | Initial notification | |
| 3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||
| a) | Name | Concurrent Technologies Plc | |
| b) | LEI | 213800422HXP2X6UPD94 | |
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
| a) | Description of the Financial instrument, type of instrument | Ordinary shares of 1 pence each | |
| | Identification code | GB0002183191 | |
| b) | Nature of the Transaction | Exercise of Options | |
| c) | Price(s) and volume(s) | Price(s) | Volume(s) |
| 39 pence | 150,000 ordinary shares | ||
| d) | Aggregated information Aggregated volume price | N/A - Single Transaction | |
| e) | Date of the transaction | 9 September 2024 | |
| f) | Place of the transaction | AIM, London Stock Exchange | |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.